Sharper & Granite LLC decreased its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 31.7% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 8,635 shares of the exchange traded fund’s stock after selling 4,013 shares during the quarter. Sharper & Granite LLC’s holdings in SPDR S&P Biotech ETF were worth $865,000 at the end of the most recent reporting period.
A number of other large investors have also recently bought and sold shares of XBI. DHJJ Financial Advisors Ltd. acquired a new position in shares of SPDR S&P Biotech ETF in the 2nd quarter valued at approximately $25,000. Capital A Wealth Management LLC acquired a new stake in shares of SPDR S&P Biotech ETF during the 2nd quarter worth approximately $26,000. Johnson Financial Group Inc. bought a new position in SPDR S&P Biotech ETF in the second quarter valued at approximately $31,000. Twin Peaks Wealth Advisors LLC acquired a new position in SPDR S&P Biotech ETF during the second quarter valued at approximately $32,000. Finally, AlphaCore Capital LLC raised its position in SPDR S&P Biotech ETF by 6,650.0% during the second quarter. AlphaCore Capital LLC now owns 540 shares of the exchange traded fund’s stock valued at $45,000 after purchasing an additional 532 shares in the last quarter.
SPDR S&P Biotech ETF Stock Performance
Shares of XBI stock opened at $126.30 on Friday. SPDR S&P Biotech ETF has a fifty-two week low of $66.66 and a fifty-two week high of $126.50. The company has a market cap of $7.67 billion, a PE ratio of 11.47 and a beta of 0.93. The stock’s fifty day moving average price is $116.73 and its two-hundred day moving average price is $99.78.
SPDR S&P Biotech ETF Profile
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.
Further Reading
- Five stocks we like better than SPDR S&P Biotech ETF
- Turn your “dead money” into $306+ monthly (starting this month)
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
- Washington prepares for war
- Put $1,000 into this stock by Jan 1 [Not NVDA]
- The McDonald’s Secret
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.
